We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Combination of Asciminib, a Novel and Specific BCR-ABL1 Inhibitor, Plus Imatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results.
- Authors
Talpaz, Moshe; Cortes, Jorge; Lang, Fabian; Kim, Dong-Wook; Réa, Delphine; Mauro, Michael J.; Minami, Hironobu; Breccia, Massimo; DeAngelo, Daniel J.; Hochhaus, Andreas; Goh, Yeow Tee; Le Coutre, Philipp D.; Sondhi, Manu; Mishra, Kaushal; Hourcade-Potelleret, Florence; Vanasse, Gary; Aimone, Paola; Hughes, Timothy P.
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2019, Vol 19, pS287
- ISSN
2152-2650
- Publication type
Article
- DOI
10.1016/j.clml.2019.07.231